| BRAND NAME | COMPOSITION | MANUFACTURER | PACKING |
| Procabazi | Cabazitaxel 60mg | Glenmark Pharmaceuticals Ltd. | 1 Vial & 1 Diluent |
Cabazitaxel is used to treat metastatic castration-resistant prostate cancer. It was first approved by the FDA on June 17, 2010.
Procabazi
Cabazitaxel is used to treat metastatic castration-resistant prostate cancer. It was first approved by the FDA on June 17, 2010.
Description
Related products
Endoxan
Descriptions. Cyclophosphamide is used to treat cancer of the ovaries, breast, blood and lymph system, and nerves (mainly in children). Cyclophosphamide is also used for retinoblastoma (a type of eye cancer mainly in children), multiple myeloma (cancer in the bone marrow), and mycosis fungoides (tumors on the skin).
Reviews
There are no reviews yet.